MPO and colitis: Our data showed that intra-rectal administration of madecassic acid (25 mg/kg) effectively ameliorated colitis in mice, as confirmed by reducing DAI scores (Figure 1f), protecting against colon shortening (Figure 1g), decreasing MPO activity (Figure 1h) and attenuating pathological lesions (Figure 1i and Supplementary Figure S1).